Latest It Compliance News

Pact Group Holdings Ltd has requested suspension of its shares from ASX trading as it prepares for removal from the official list, signaling a major shift for investors.

Advanced Health Intelligence has been formally delisted from NASDAQ due to shareholder equity deficiencies but is actively pursuing ASX reinstatement as a critical step toward regaining its dual-listing status.

INOVIQ Limited reports strong clinical validation for its EXO-OC ovarian cancer screening test and promising preclinical results for CAR-exosome therapeutics targeting aggressive cancers.

G8 Education faces ASX scrutiny over its handling of sensitive information about a former employee, with the regulator questioning the company’s disclosure practices despite GEM’s insistence of compliance.

Uvre Limited has completed its acquisition of promising New Zealand gold assets and appointed seasoned mining executives to its board, setting the stage for an accelerated exploration phase.

Bowen Coking Coal Limited has had its ASX trading suspension lifted following its disclosure on funding efforts amid challenging market conditions. The company confirmed compliance with ASX rules, paving the way for immediate reinstatement.

Bowen Coking Coal Limited (BCB) has responded to ASX inquiries about its liquidity challenges, working capital needs from transitioning to an owner-operator model, and deteriorating operating margins, affirming compliance and financial viability despite market pressures.

West Wits Mining appoints CEO Rudi Deysel as Managing Director and adds Keith Middleton as non-executive director, while veteran board member Hulme Scholes retires after 14 years. These changes come as the company transitions into operational gold production at its Qala Shallows project in South Africa.

Trigg Minerals has withdrawn previously reported mineral resource estimates for its Antimony Canyon Project after ASX compliance review, while reaffirming confidence in ongoing exploration efforts.

Orcoda Limited has locked in six new multi-year SaaS contracts with Australian community transport providers following a successful government-backed trial, pushing its annual recurring revenue to approximately $5 million.

Alterity Therapeutics has responded to an ASX inquiry about its recent share price and volume spike, confirming no undisclosed information but highlighting imminent clinical data releases and investor roadshows as possible drivers.

Kinterra Capital has increased its takeover offer for New World Resources Limited to A$0.064 per share and extended the acceptance deadline to July 17, signaling renewed confidence in securing control.